Strategies to Develop Na,K-ATPase-α4 Inhibitors as Male Contraceptives
Shameem S Syeda1, Gladis Sánchez2, Jeffrey P McDermott2
1Department of Medicinal Chemistry, Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA.
Developing novel male contraceptives is crucial. Researchers simplified complex molecules to create new NKAα4 inhibitors, with compound 45 showing promise for non-hormonal male contraception by reducing sperm motility and blocking fertilization.
Area of Science:
- Biochemistry
- Reproductive Biology
- Medicinal Chemistry
Background:
- Male contraception faces unmet needs, with limited options available.
- Na,K-ATPase α4 (NKA α4) in sperm flagella is a validated target for male contraceptives due to its role in motility and fertility.
- Previous NKAα4 inhibitors had complex structures hindering optimization.
Purpose of the Study:
- To develop novel, simplified steroidal and non-steroidal NKAα4 inhibitors.
- To evaluate these compounds for NKAα4 inhibition, sperm motility reduction, and contraceptive potential.
- To identify promising lead compounds for non-hormonal male contraceptive development.
Main Methods:
- Structure-activity relationship (SAR) studies were used to simplify existing cardenolide scaffolds.
- Novel steroidal and non-steroidal analogs were synthesized.
- In vitro assays assessed NKAα4 inhibition, sperm motility, viability, and reversibility.
- In vivo and fertilization assays were performed for promising candidates.
Main Results:
- Synthesized compounds effectively inhibited NKAα4 with picomolar IC50 values.
- Both steroidal and non-steroidal series reduced sperm motility by up to 50%.
- Compounds 13 and 45 showed high specificity for NKAα4 over NKAα1, without affecting sperm viability or reversibility.
- Compound 45 demonstrated potent NKAα4 inhibition, reduced sperm motility in vitro and in vivo, and blocked fertilization in vitro.
Conclusions:
- Structural simplification yielded potent NKAα4 inhibitors with contraceptive potential.
- Compound 45 is a promising lead candidate for non-hormonal male contraception.
- The newly generated compound series possess key characteristics for further development as male contraceptive agents.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Related Concept Videos
ATP Synthase: Mechanism
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Antihypertensive Drugs: Vasodilators
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Birth Control Methods
Primary Active Transport
